BLUE BIOFUELS, INC. (BIOF) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
21/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseBIOF / S&P -14.89% / 15.20% |
LoseBIOF / S&P BIOF unavailable / 15.00% |
WinBIOF / S&P 125.00% / 50.40% |
| 2026-Q11/3 |
LoseBIOF / S&P -25.79% / -4.33% |
LoseBIOF / S&P BIOF unavailable / 11.30% |
WinBIOF / S&P 233.33% / 27.70% |
| 2025-Q41/3 |
LoseBIOF / S&P 2.15% / 2.65% |
LoseBIOF / S&P BIOF unavailable / 9.00% |
WinBIOF / S&P 80.00% / 13.40% |
| 2025-Q32/3 |
WinBIOF / S&P 19.23% / 8.12% |
LoseBIOF / S&P BIOF unavailable / 4.61% |
WinBIOF / S&P 1000.00% / 13.45% |
| 2025-Q21/3 |
WinBIOF / S&P 26.83% / 10.94% |
LoseBIOF / S&P BIOF unavailable / 4.83% |
LoseBIOF / S&P -50.00% / 10.63% |
| 2025-Q11/3 |
WinBIOF / S&P 10.81% / -4.27% |
LoseBIOF / S&P BIOF unavailable / 4.98% |
LoseBIOF / S&P -70.00% / 10.57% |
| 2024-Q40/3 |
LoseBIOF / S&P -13.95% / 2.41% |
LoseBIOF / S&P BIOF unavailable / 5.25% |
LoseBIOF / S&P -54.55% / 6.15% |
| 2024-Q31/3 |
WinBIOF / S&P 61.25% / 5.89% |
LoseBIOF / S&P BIOF unavailable / 5.89% |
LoseBIOF / S&P BIOF unavailable / 6.11% |
| 2024-Q20/3 |
LoseBIOF / S&P -23.81% / 4.28% |
LoseBIOF / S&P BIOF unavailable / 5.38% |
LoseBIOF / S&P BIOF unavailable / 5.12% |
| 2024-Q11/3 |
WinBIOF / S&P 28.05% / 10.56% |
LoseBIOF / S&P BIOF unavailable / 5.71% |
LoseBIOF / S&P BIOF unavailable / 5.59% |
| 2023-Q40/3 |
LoseBIOF / S&P -44.59% / 11.69% |
LoseBIOF / S&P BIOF unavailable / 6.81% |
LoseBIOF / S&P BIOF unavailable / 7.78% |
| 2023-Q31/3 |
WinBIOF / S&P -2.63% / -3.27% |
LoseBIOF / S&P BIOF unavailable / 7.52% |
LoseBIOF / S&P BIOF unavailable / -5.03% |
| 2023-Q20/3 |
LoseBIOF / S&P -8.43% / 8.74% |
LoseBIOF / S&P BIOF unavailable / 9.50% |
LoseBIOF / S&P BIOF unavailable / -8.57% |
| 2023-Q11/3 |
WinBIOF / S&P 14.48% / 7.50% |
LoseBIOF / S&P BIOF unavailable / 10.77% |
LoseBIOF / S&P BIOF unavailable / -15.69% |
| 2022-Q40/3 |
LoseBIOF / S&P -13.17% / 7.56% |
LoseBIOF / S&P BIOF unavailable / 11.88% |
LoseBIOF / S&P BIOF unavailable / -17.99% |
| 2022-Q31/3 |
WinBIOF / S&P -1.76% / -4.88% |
LoseBIOF / S&P BIOF unavailable / 13.47% |
LoseBIOF / S&P BIOF unavailable / -1.41% |
| 2022-Q21/3 |
WinBIOF / S&P 6.25% / -16.10% |
LoseBIOF / S&P BIOF unavailable / 13.71% |
LoseBIOF / S&P BIOF unavailable / 11.04% |
| 2022-Q10/3 |
LoseBIOF / S&P -35.74% / -4.60% |
LoseBIOF / S&P BIOF unavailable / 15.97% |
LoseBIOF / S&P BIOF unavailable / 42.23% |
| 2021-Q40/3 |
LoseBIOF / S&P -2.35% / 11.03% |
LoseBIOF / S&P BIOF unavailable / 15.00% |
LoseBIOF / S&P BIOF unavailable / 96.40% |
| 2021-Q30/3 |
LoseBIOF / S&P -15.84% / 0.58% |
LoseBIOF / S&P BIOF unavailable / 10.77% |
LoseBIOF / S&P BIOF unavailable / 69.42% |
| 2021-Q20/3 |
LoseBIOF / S&P -33.99% / 8.55% |
LoseBIOF / S&P BIOF unavailable / 6.58% |
LoseBIOF / S&P BIOF unavailable / 51.81% |
| 2021-Q11/3 |
WinBIOF / S&P 359.00% / 6.17% |
LoseBIOF / S&P BIOF unavailable / -1.06% |
LoseBIOF / S&P BIOF unavailable / 7.39% |
| 2020-Q40/3 |
LoseBIOF / S&P -5.66% / 12.15% |
LoseBIOF / S&P BIOF unavailable / -3.72% |
LoseBIOF / S&P BIOF unavailable / -33.42% |
| 2020-Q30/3 |
LoseBIOF / S&P 8.16% / 8.93% |
LoseBIOF / S&P BIOF unavailable / -2.04% |
LoseBIOF / S&P BIOF unavailable / -27.10% |
| 2020-Q21/3 |
WinBIOF / S&P 81.48% / 20.54% |
LoseBIOF / S&P BIOF unavailable / -0.46% |
LoseBIOF / S&P BIOF unavailable / -27.11% |
| 2020-Q11/3 |
WinBIOF / S&P 5.88% / -19.60% |
LoseBIOF / S&P BIOF unavailable / 3.47% |
LoseBIOF / S&P BIOF unavailable / -14.75% |
| 2019-Q40/3 |
LoseBIOF / S&P 2.00% / 9.07% |
LoseBIOF / S&P BIOF unavailable / 5.36% |
LoseBIOF / S&P BIOF unavailable / 2.99% |
| 2019-Q31/3 |
WinBIOF / S&P 8.70% / 1.70% |
LoseBIOF / S&P BIOF unavailable / 5.02% |
LoseBIOF / S&P BIOF unavailable / 0.21% |
| 2019-Q21/3 |
WinBIOF / S&P 76.92% / 4.30% |
LoseBIOF / S&P BIOF unavailable / 6.64% |
LoseBIOF / S&P BIOF unavailable / 8.65% |
| 2019-Q11/3 |
WinBIOF / S&P 550.00% / 13.65% |
LoseBIOF / S&P BIOF unavailable / 8.12% |
LoseBIOF / S&P BIOF unavailable / 14.29% |
| 2018-Q40/3 |
LoseBIOF / S&P -85.19% / -13.52% |
LoseBIOF / S&P BIOF unavailable / 9.05% |
LoseBIOF / S&P BIOF unavailable / 18.23% |
| 2018-Q30/3 |
LoseBIOF / S&P 3.85% / 7.71% |
LoseBIOF / S&P BIOF unavailable / 10.21% |
LoseBIOF / S&P BIOF unavailable / 19.06% |
| 2018-Q20/3 |
LoseBIOF / S&P -29.73% / 3.43% |
LoseBIOF / S&P BIOF unavailable / 9.03% |
LoseBIOF / S&P BIOF unavailable / 14.46% |
| 2018-Q11/3 |
WinBIOF / S&P 32.14% / -0.76% |
LoseBIOF / S&P BIOF unavailable / 7.68% |
LoseBIOF / S&P BIOF unavailable / 12.46% |
| 2017-Q40/3 |
LoseBIOF / S&P -85.03% / 6.64% |
LoseBIOF / S&P BIOF unavailable / 7.03% |
LoseBIOF / S&P BIOF unavailable / 13.82% |
| 2017-Q30/3 |
LoseBIOF / S&P -50.79% / 4.48% |
LoseBIOF / S&P BIOF unavailable / 5.68% |
LoseBIOF / S&P BIOF unavailable / 17.57% |
| 2017-Q21/3 |
WinBIOF / S&P 239.29% / 3.09% |
LoseBIOF / S&P BIOF unavailable / 4.83% |
LoseBIOF / S&P BIOF unavailable / 17.74% |
| 2017-Q10/3 |
LoseBIOF / S&P -42.86% / 6.07% |
LoseBIOF / S&P BIOF unavailable / 3.67% |
LoseBIOF / S&P BIOF unavailable / 13.32% |
| 2016-Q40/3 |
LoseBIOF / S&P -24.62% / 3.82% |
LoseBIOF / S&P BIOF unavailable / 2.09% |
LoseBIOF / S&P BIOF unavailable / 7.05% |
| 2016-Q30/3 |
LoseBIOF / S&P -27.78% / 3.85% |
LoseBIOF / S&P BIOF unavailable / 0.20% |
LoseBIOF / S&P BIOF unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BIOF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.72% | 20.78% |
| Annualized return | -47.72% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BIOF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -59.29% | 83.14% |
| Annualized return | -16.45% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BIOF total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -65.67% | 319.30% |
| Annualized return | -10.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.